Literature DB >> 15987745

Asymmetric dimethylarginine and kidney disease--marker or mediator?

Patrick Vallance, James Leiper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15987745     DOI： 10.1681/ASN.2005050539

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  9 in total

1.  Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

Authors:  Gin-Fu Chen; Laszlo Wagner; Jennifer M Sasser; Sergey Zharikov; Natasha C Moningka; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2010-05-19       Impact factor: 5.992

Review 2.  Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

Review 3.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

4.  Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.

Authors:  Dan Wang; Svend Strandgaard; Jens Iversen; Christopher S Wilcox
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

5.  Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.

Authors:  Arthur J Pope; Kanchana Karrupiah; Patrick N Kearns; Yong Xia; Arturo J Cardounel
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 6.  Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.

Authors:  Arthur J Pope; Kanchana Karuppiah; Arturo J Cardounel
Journal:  Pharmacol Res       Date:  2009-08-12       Impact factor: 7.658

Review 7.  Cellular ADMA: regulation and action.

Authors:  Tom Teerlink; Zaiming Luo; Fredrik Palm; Christopher S Wilcox
Journal:  Pharmacol Res       Date:  2009-08-12       Impact factor: 7.658

8.  Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children.

Authors:  Dorota Drożdż; Monika Łątka; Tomasz Drożdż; Krystyna Sztefko; Przemko Kwinta
Journal:  Oxid Med Cell Longev       Date:  2018-02-28       Impact factor: 6.543

9.  ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography.

Authors:  Fabian Heunisch; Lyubov Chaykovska; Gina von Einem; Markus Alter; Thomas Dschietzig; Axel Kretschmer; Karl-Heinz Kellner; Berthold Hocher
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.